Latest & greatest articles for adhd

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on adhd or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on adhd and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

ADHD

ADHD (or Attention deficit hyperactivity disorder) is a neurodevelopmental type mental disorder. It is characterised two main categories of two types of behavioural problems:

  • inattentiveness
  • hyperactivity and impulsiveness

Most people with ADHD have problems that fall into both categories, but it doesn’t have to be the case. If a person just has inattentiveness it is referred to as attention deficit disorder (ADD).

Methylphenidate is a commonly used medication used to treat patients suffering from attention-deficit hyperactivity disorder. Methylphenidate is part of a group of drugs known as stimulants. Central nervous system stimulants help change the amounts of natural substances in the brain. But it is not the only intervention; others include Bupropion, exercise and CBT (Cognitive behavioural therapy).

Extensive ADHD research and case studies have been carried out over numerous years. Trip has unrivalled coverage of the evidence base including systematic reviews, clinical trials, clinical guidelines and case studies.

Studies are ongoing to assess the safety and effectiveness of stimulants used on children with ADHD and intellectual disabilities as well as in other populations and other interventions. Trip also includes ongoing controlled trials and ongoing systematic reviews (via the PROSPERO database).

Top results for adhd

201. Dexmethylphenidate extended-release capsules in children with attention-deficit/hyperactivity disorder (Abstract)

Dexmethylphenidate extended-release capsules in children with attention-deficit/hyperactivity disorder This study compared once-daily dexmethylphenidate extended release (D-MPH-ER) 20 mg/day and placebo over 12 hours in children ages 6 to 12 with attention-deficit/hyperactivity disorder (ADHD) in a laboratory classroom setting.All of the children were stabilized for > or =2 weeks on a total dose (nearest equivalent) MPH 40 mg/day or immediate-release D-MPH 20 mg/day before screening. After (...) hours, SKAMP subscale scores, and math test results over 12 hours.Sixty-eight children were randomized, with 67 completing the study. Onset of action was indicated by a significant difference between D-MPH-ER and placebo at 0.5 hour on the SKAMP combined score (p = .001). For efficacy measures, differences from placebo were significant at all points between 0.5 and 12 hours (p < .001 top = .013).D-MPH-ER provided sustained improvement in attention, deportment, and academic productivity throughout

2008 EvidenceUpdates Controlled trial quality: uncertain

202. Attention deficit hyperactivity disorder: diagnosis and management

Attention deficit hyperactivity disorder: diagnosis and management Attention deficit hyperactivity disorder: diagnosis and management | Guidance | NICE Attention deficit hyperactivity disorder: diagnosis and management Clinical guideline [CG72] Published date: September 2008 Guidance This guidance has been updated and replaced by . Explore © NICE [year]. All rights reserved. Subject to .

2008 National Institute for Health and Clinical Excellence - Clinical Guidelines

203. Hypericum perforatum (St John's wort) for attention-deficit/hyperactivity disorder in children and adolescents: a randomized controlled trial. Full Text available with Trip Pro

Hypericum perforatum (St John's wort) for attention-deficit/hyperactivity disorder in children and adolescents: a randomized controlled trial. Stimulant medication can effectively treat 60% to 70% of youth with attention-deficit/hyperactivity disorder (ADHD). Yet many parents seek alternative therapies, and Hypericum perforatum (St John's wort) is 1 of the top 3 botanicals used.To determine the efficacy and safety of H. perforatum for the treatment of ADHD in children.Randomized, double-blind (...) , placebo-controlled trial conducted between March 2005 and August 2006 at Bastyr University, Kenmore, Washington, among a volunteer sample of 54 children aged 6 to 17 years who met Diagnostic and Statistical Manual of Mental Disorders (Fourth Edition) criteria for ADHD by structured interview.After a placebo run-in phase of 1 week, participants were randomly assigned to receive 300 mg of H. perforatum standardized to 0.3% hypericin (n = 27) or a matched placebo (n = 27) 3 times daily for 8 weeks. Other

2008 JAMA Controlled trial quality: predicted high

204. Collaborative consultation increases use of medication titration trials but not behaviour in children with ADHD

Collaborative consultation increases use of medication titration trials but not behaviour in children with ADHD Collaborative consultation increases use of medication titration trials but not behaviour in children with ADHD | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Collaborative consultation increases use of medication titration trials but not behaviour in children with ADHD Article Text Therapeutics Collaborative consultation

2008 Evidence-Based Mental Health

205. Attention deficit hyperactivity disorder is associated with poorer academic performance

Attention deficit hyperactivity disorder is associated with poorer academic performance Attention deficit hyperactivity disorder is associated with poorer academic performance | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Attention deficit hyperactivity disorder is associated with poorer academic performance Article Text Prognosis Attention deficit hyperactivity disorder is associated with poorer academic performance Statistics from

2008 Evidence-Based Mental Health

206. [Treatment of ADHD (Attention-Deficit/Hyperactivity Disorder) in adults with central stimulants]

[Treatment of ADHD (Attention-Deficit/Hyperactivity Disorder) in adults with central stimulants] Behandling av ADHD (Attention-deficit/hyperactivity disorder) hos vuxna, med centralstimulerande medel [Treatment of ADHD (Attention-Deficit/Hyperactivity Disorder) in adults with central stimulants] Behandling av ADHD (Attention-deficit/hyperactivity disorder) hos vuxna, med centralstimulerande medel [Treatment of ADHD (Attention-Deficit/Hyperactivity Disorder) in adults with central stimulants (...) ] The Regional Health Technology Assessment Centre (HTA-centrum) Citation The Regional Health Technology Assessment Centre (HTA-centrum). Behandling av ADHD (Attention-deficit/hyperactivity disorder) hos vuxna, med centralstimulerande medel. [Treatment of ADHD (Attention-Deficit/Hyperactivity Disorder) in adults with central stimulants] Gothenburg: The Regional Health Technology Assessment Centre (HTA-centrum). HTA-rapport 2008:10. 2008 Authors' objectives Are ADHD symptoms positively affected, in adult

2008 Health Technology Assessment (HTA) Database.

207. An estimated 3.4% of adults have adult attention-deficit hyperactivity disorder

An estimated 3.4% of adults have adult attention-deficit hyperactivity disorder An estimated 3.4% of adults have adult attention-deficit hyperactivity disorder | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional (...) accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here An estimated 3.4% of adults have adult attention-deficit hyperactivity disorder Article Text Prevalence An estimated 3.4% of adults have adult attention-deficit hyperactivity disorder Statistics from Altmetric.com Request

2008 Evidence-Based Mental Health

208. Psychopharmacological and other treatments in preschool children with attention-deficit/hyperactivity disorder: current evidence and practice Full Text available with Trip Pro

for attention-deficit and hyperactivity disorder (ADHD) in preschool children. Searching MEDLINE, PsycINFO, CINAHL, ERIC, Cochrane Database of Systematic Reviews and DARE were searched for English-language studies from 1967 to 2007. Search terms were not reported. Reference lists of included articles were searched to identify additional articles. Study selection Eligible studies comprised controlled and non-controlled studies that included at least some children or under six years old and/or attending (...) Psychopharmacological and other treatments in preschool children with attention-deficit/hyperactivity disorder: current evidence and practice Psychopharmacological and other treatments in preschool children with attention-deficit/hyperactivity disorder: current evidence and practice Psychopharmacological and other treatments in preschool children with attention-deficit/hyperactivity disorder: current evidence and practice Ghuman JK, Arnold LE, Anthony BJ CRD summary This review assessed various

2008 DARE.

209. Treatment of adult ADHD: Is current knowledge useful to clinicians?

Treatment of adult ADHD: Is current knowledge useful to clinicians? Treatment of adult ADHD: Is current knowledge useful to clinicians? Treatment of adult ADHD: Is current knowledge useful to clinicians? Torgersen T, Gjervan B, Rasmussen K CRD summary This review concluded there was good support for the pharmacological and psychotherapeutic treatment of attention deficit hyperactivity disorder in adults. It is likely that the review was affected by multiple sources of error and bias, which (...) means that the conclusions should not be regarded as reliable. Authors' objectives To review the literature on pharmacological and psychotherapeutic treatment for adult attention deficit hyperactivity disorder (ADHD) with a particular emphasis on comorbidity. Searching The following databases were searched to January 2007 and search terms were not reported: PubMed, EMBASE, PsycINFO and the Cochrane Library. References from included studies were also searched for relevant papers. Study selection

2008 DARE.

210. Evidence-based psychosocial treatments for attention-deficit/hyperactivity disorder Full Text available with Trip Pro

Evidence-based psychosocial treatments for attention-deficit/hyperactivity disorder Evidence-based psychosocial treatments for attention-deficit/hyperactivity disorder Evidence-based psychosocial treatments for attention-deficit/hyperactivity disorder Pelham WE, Fabiano GA CRD summary This review evaluated the evidence base of psychosocial treatments for attention-deficit/hyperactivity disorder (ADHD) and apparently concluded that evidence-based behavioural interventions should constitute part (...) of the services received by children with ADHD. Given the poor reporting of the review process and potential for missed studies, the authors' conclusions should be interpreted with caution. Authors' objectives To evaluate the evidence base of psychosocial treatments for attention-deficit/hyperactivity disorder (ADHD). Searching MEDLINE and PsycINFO were searched from January 1997 to September 2006; search terms were not reported. Manual searches of contents pages from 13 journals were undertaken

2008 DARE.

211. Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis

Comparative benefits and harms of competing medications for adults with attention-deficit hyperactivity disorder: a systematic review and indirect comparison meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2008 DARE.

212. A modeled economic evaluation comparing atomoxetine with stimulant therapy in the treatment of children with attention-deficit/hyperactivity disorder in the United Kingdom Full Text available with Trip Pro

with attention deficit hyperactivity disorder (ADHD) in comparison with the current alternatives, in patient groups with varying treatment histories and existence of co-morbidities, which ruled out stimulant medication. Atomoxetine offered value for money in the treatment of ADHD from the perspective of the National Health Service. The study considered different patient populations and was based on valid methodology, which makes the authors’ conclusions more valid and robust. Type of economic evaluation Cost (...) -utility analysis Study objective The objective was to examine the cost-effectiveness of atomoxetine for the treatment of children with attention deficit hyperactivity disorder (ADHD) in comparison with the current alternatives, in different patient groups, according to their treatment history and the existence of co-morbidities, which rule out stimulant medication. Interventions Oral atomoxetine at an average 1.1 capsule per day dose was compared with methylphenidate hydrochloride (MPH), either

2008 NHS Economic Evaluation Database.

213. Long-acting methylphenidate-OROS in youths with attention-deficit hyperactivity disorder suboptimally controlled with immediate-release methylphenidate: a study of cost effectiveness in the Netherlands

and the study was well presented, especially the economic details. The authors’ conclusions appear to be robust. Type of economic evaluation Cost-utility analysis Study objective This study examined the cost-effectiveness of long-acting methylphenidate osmotic release oral system (OROS) for the treatment of young people (8 to 18 years) with attention deficit hyperactivity disorder (ADHD), for whom treatment with immediate-release (IR) methylphenidate was effective, but sub-optimal due to problems (...) . A randomized, controlled, effectiveness trial of OROS-methylphenidate compared to usual care with immediate-release methylphenidate in attention-deficit-hyperactivity-disorder. Can J Clin Pharmacol 2006;13:e50-62. Vanoverbeke N, Annemans L, Ingham M, et al. A cost analysis of the management of attention-deficit/hyperactivity disorder (ADHD) in children in the UK. J Med Economics 2003;6:79-94. Wolraich ML, Greenhill LL, Pelham W, et al. Randomized, controlled trial of oros methylphenidate once a day

2008 NHS Economic Evaluation Database.

214. Modafinil improves symptoms of ADHD compared with placebo in young people Full Text available with Trip Pro

Modafinil improves symptoms of ADHD compared with placebo in young people Modafinil improves symptoms of ADHD compared with placebo in young people | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts Username (...) * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Modafinil improves symptoms of ADHD compared with placebo in young people Article Text Therapeutics Modafinil improves symptoms of ADHD compared with placebo in young people Statistics from Altmetric.com Request Permissions If you wish to reuse

2007 Evidence-Based Mental Health

215. Methylphenidate may improve symptoms but does not increase response compared with placebo in preschool children with ADHD. (Abstract)

Methylphenidate may improve symptoms but does not increase response compared with placebo in preschool children with ADHD. 17459991 2007 05 22 2007 04 26 1362-0347 10 2 2007 May Evidence-based mental health Evid Based Ment Health Methylphenidate may improve symptoms but does not increase response compared with placebo in preschool children with ADHD. 60 Wolraich Mark L ML OU Child Study Center, Oklahoma City, Oklahoma, USA. eng Comment Journal Article England Evid Based Ment Health 100883413

2007 Evidence-Based Mental Health Controlled trial quality: uncertain

216. The short form adult attention deficit/hyperactivity self-report scale is a useful diagnostic measure Full Text available with Trip Pro

scale is a useful diagnostic measure Statistics from Altmetric.com Kessler RC, Adler L, Ames M, et al . The World Health Organization adult ADHD self-report scale (ASRS): a short screening scale for use in the general population. Psychol Med 2005 ; 35 : 245 –56. Q Do the long and short forms of the attention deficit/hyperactivity disorder (ADHD) self-report scale effectively diagnose ADHD in adults? METHODS Design: Prospective diagnostic cohort study. Setting: General population, USA; interviews (...) The short form adult attention deficit/hyperactivity self-report scale is a useful diagnostic measure The short form adult attention deficit/hyperactivity self-report scale is a useful diagnostic measure | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal

2007 Evidence-Based Mental Health

217. Atomoxetine improves teacher rated symptoms in children with ADHD more than placebo

Atomoxetine improves teacher rated symptoms in children with ADHD more than placebo Atomoxetine improves teacher rated symptoms in children with ADHD more than placebo | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Atomoxetine improves teacher rated symptoms in children with ADHD more than placebo Article Text Therapeutics Atomoxetine improves teacher rated symptoms in children with ADHD more than placebo Statistics from

2007 Evidence-Based Mental Health

218. Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents: meta-analysis and meta-regression analysis

Efficacy and safety of atomoxetine for attention-deficit/hyperactivity disorder in children and adolescents: meta-analysis and meta-regression analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2007 DARE.

219. Systematic review of pharmacotherapy of disruptive behavior disorders in children and adolescents

Systematic review of pharmacotherapy of disruptive behavior disorders in children and adolescents Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2007 DARE.

220. Adding multimodal behavioural therapy to methylphenidate does not improve ADHD outcomes

Adding multimodal behavioural therapy to methylphenidate does not improve ADHD outcomes Adding multimodal behavioural therapy to methylphenidate does not improve ADHD outcomes | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Adding multimodal behavioural therapy to methylphenidate does not improve ADHD outcomes Article Text Therapeutics Adding multimodal behavioural therapy to methylphenidate does not improve ADHD outcomes Statistics from

2007 Evidence-Based Mental Health